Latest Period
Q2 2026
Security Snapshot
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) Institutional Ownership
CUSIP: 881624209
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
671
Shares (Excl. Options)
731,354,153
Price
$33.88
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Symbol
- TEVA on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 731,354,153
- Total 13F value
- $24,721,529,826
- Portfolio coverage rank
- 0.02%
- Share change
- +58,674,530
- Value change
- +$2,001,222,515
- Number of holders
- 671
- Shares outstanding
- 1,148,777,709
- SEC-reported price per share
- $30.15
- Insider filing price
- $30.15
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share is tracked under CUSIP 881624209.
- 671 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 650 to 671 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $20,141,721,944 to $24,721,529,826.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 671 institutions filings for Q2 2026.
Security key
881624209
Latest holder period
Q2 2026
13F holders
671
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
TEVA full holder history
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings
TEVA PHARMACEUTICAL INDUSTRIES LTD company facts
TEVA PHARMACEUTICAL INDUSTRIES LTD insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 881624209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
TEVA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Migdal Insurance & Financial Holdings Ltd. | 5.4% | $2,022,794,213 | 61,689,363 | Migdal Insurance & Financial Holdings Ltd | 31 Dec 2025 | |||
| MENORA MIVTACHIM HOLDINGS LTD. | 5% | $961,943,099 | 57,395,173 | Menora Mivtachim Holdings Ltd | 16 Jul 2025 | |||
| Phoenix Financial Ltd. | 5% | $961,741,722 | 57,383,158 | Phoenix Financial Ltd. | 14 Jul 2025 |
As of 30 Jun 2026, 671 institutional investors reported holding 731,354,153 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA). This represents 64% of the company’s total 1,148,777,709 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
47%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.6% | 63,894,301 | -1.9% | 0.03% | $2,164,738,902 |
| Harel Insurance Investments & Financial Services Ltd. | 4.2% | 48,138,805 | +4.7% | 7.9% | $1,630,943,000 |
| Phoenix Financial Ltd. | 3.7% | 42,933,367 | +0.36% | 9.9% | $1,454,582,474 |
| WCM INVESTMENT MANAGEMENT, LLC | 3.6% | 41,315,232 | +1.2% | 2.5% | $1,376,210,378 |
| Clal Insurance Enterprises Holdings Ltd | 3.5% | 40,596,506 | +5.6% | 6.1% | $1,366,377,000 |
| MENORA MIVTACHIM HOLDINGS LTD. | 3.5% | 39,854,383 | +0.58% | 5.3% | $1,350,266,496 |
| Migdal Insurance & Financial Holdings Ltd. | 3.4% | 38,922,212 | +2.7% | 8.4% | $1,318,684,543 |
| NORGES BANK | 2.8% | 32,299,753 | 0.11% | $1,094,315,632 | |
| FMR LLC | 2.6% | 30,258,016 | -8.7% | 0.04% | $1,025,141,579 |
| Lingotto Investment Management LLP | 1.8% | 20,205,943 | -27% | 15% | $684,577,349 |
| STATE STREET CORP | 1.6% | 18,936,548 | +6.4% | 0.02% | $641,570,246 |
| Rubric Capital Management LP | 1.4% | 15,575,000 | +2.1% | 4.8% | $527,681,000 |
| Capital World Investors | 1.1% | 12,536,035 | +42% | 0.05% | $424,720,866 |
| Altshuler Shaham Ltd | 1.1% | 12,466,895 | +8.8% | 5.2% | $411,809,423 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 11,607,196 | +9.9% | 0.02% | $391,014,749 |
| MEITAV INVESTMENT HOUSE LTD | 0.87% | 9,947,045 | 2.3% | $336,876,210 | |
| NORTHERN TRUST CORP | 0.69% | 7,956,873 | +4.2% | 0.03% | $269,578,857 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.67% | 7,671,157 | +5.8% | 0.04% | $259,898,799 |
| JPMORGAN CHASE & CO | 0.61% | 6,981,234 | +3.2% | 0.01% | $232,544,997 |
| MORGAN STANLEY | 0.61% | 6,968,719 | -6.2% | 0.01% | $236,100,276 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 0.57% | 6,593,221 | +362% | 0.67% | $223,369,747 |
| Alyeska Investment Group, L.P. | 0.54% | 6,257,579 | +13% | 0.55% | $212,006,777 |
| GOLDMAN SACHS GROUP INC | 0.53% | 6,129,240 | +27% | 0.02% | $207,658,651 |
| BESSEMER GROUP INC | 0.49% | 5,581,600 | +28% | 0.26% | $189,104,000 |
| Polar Capital Holdings Plc | 0.45% | 5,212,749 | +0.73% | 0.5% | $176,607,936 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 731,354,153 | $24,721,529,826 | +$2,001,222,515 | $33.88 | 671 |
| 2026 Q1 | 672,316,220 | $20,141,721,944 | -$615,393,432 | $30.12 | 650 |
| 2025 Q4 | 686,977,855 | $21,442,593,594 | +$1,230,700,950 | $31.21 | 628 |
| 2025 Q3 | 657,155,100 | $13,261,324,401 | -$1,074,548,979 | $20.20 | 544 |
| 2025 Q2 | 712,590,449 | $11,941,932,547 | +$36,824,124 | $16.76 | 533 |
| 2025 Q1 | 711,693,842 | $10,931,543,829 | +$519,379,518 | $15.37 | 553 |
| 2024 Q4 | 665,647,648 | $14,670,317,479 | +$818,691,314 | $22.04 | 576 |
| 2024 Q3 | 620,854,841 | $11,183,045,547 | +$327,878,111 | $18.02 | 537 |
| 2024 Q2 | 607,728,519 | $9,874,096,775 | +$630,049,704 | $16.25 | 528 |
| 2024 Q1 | 570,414,049 | $8,044,022,392 | -$52,732,472 | $14.11 | 474 |
| 2023 Q4 | 577,047,792 | $6,069,688,726 | +$223,053,462 | $10.44 | 442 |
| 2023 Q3 | 554,042,366 | $5,650,669,709 | +$626,794,069 | $10.20 | 427 |
| 2023 Q2 | 494,500,315 | $3,725,733,619 | -$615,772,920 | $7.53 | 415 |
| 2023 Q1 | 558,872,500 | $4,939,868,087 | -$36,845,034 | $8.85 | 431 |
| 2022 Q4 | 546,063,896 | $4,978,922,006 | -$17,646,117 | $9.12 | 412 |
| 2022 Q3 | 560,076,320 | $4,512,924,774 | +$430,391,292 | $8.07 | 395 |
| 2022 Q2 | 505,606,590 | $3,800,507,049 | -$46,832,800 | $7.52 | 423 |
| 2022 Q1 | 514,571,916 | $4,831,771,215 | +$15,212,208 | $9.39 | 420 |
| 2021 Q4 | 505,268,193 | $4,044,921,275 | -$275,589,149 | $8.01 | 404 |
| 2021 Q3 | 527,166,334 | $5,134,182,484 | -$316,368,771 | $9.74 | 408 |
| 2021 Q2 | 560,418,706 | $5,548,640,366 | -$132,495,361 | $9.90 | 423 |
| 2021 Q1 | 572,281,687 | $6,602,414,033 | +$11,656,292 | $11.54 | 432 |
| 2020 Q4 | 569,047,097 | $5,481,032,100 | +$43,379,354 | $9.65 | 425 |
| 2020 Q3 | 567,029,372 | $5,101,188,907 | -$198,579,913 | $9.01 | 421 |
| 2020 Q2 | 578,768,724 | $7,127,077,578 | +$321,923,360 | $12.33 | 435 |